Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 18
2022 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Small-molecule inhibitors of carboxylesterase Notum.
Zhao Y, Jolly S, Benvegnu S, Jones EY, Fish PV. Zhao Y, et al. Future Med Chem. 2021 Jun;13(11):1001-1015. doi: 10.4155/fmc-2021-0036. Epub 2021 Apr 22. Future Med Chem. 2021. PMID: 33882714 Free PMC article. Review.
Indole-thiazole hybrids with anticancer potential.
Chen L, Zhao D, Zhu K, Wang D, Li Y, Qu M, Zhuang Y. Chen L, et al. Future Med Chem. 2026 Mar;18(6):713-728. doi: 10.1080/17568919.2026.2620365. Epub 2026 Jan 30. Future Med Chem. 2026. PMID: 41612898 Review.
This review systematically summarizes the latest advances in the anticancer potential of indole-thiazole hybrids developed since 2021. To delineate the key molecular features that govern the anticancer potency of indole-thiazole hybrids, this review further presents a deta …
This review systematically summarizes the latest advances in the anticancer potential of indole-thiazole hybrids developed since 2021
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases.
Chen XF, Zhao X, Yang Z. Chen XF, et al. J Med Chem. 2021 Dec 23;64(24):17601-17626. doi: 10.1021/acs.jmedchem.1c01567. Epub 2021 Dec 2. J Med Chem. 2021. PMID: 34854680 Review.
Critical technical barriers of therapeutic aptamers are briefly discussed, followed by some future perspectives for their implementation into clinical utility....
Critical technical barriers of therapeutic aptamers are briefly discussed, followed by some future perspectives for their implementat …
Research Development, Optimization and Modifications of Anti-cancer Peptides.
Sun ZG, Zhao LH, Yeh SM, Li ZN, Ming X. Sun ZG, et al. Mini Rev Med Chem. 2021;21(1):58-68. doi: 10.2174/1389557520666200729163146. Mini Rev Med Chem. 2021. PMID: 32767954 Review.
In conclusion, it can be said that anti-cancer peptides will play a major role in the future oncologic clinic....
In conclusion, it can be said that anti-cancer peptides will play a major role in the future oncologic clinic....
Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors.
Li G, Qi W, Li X, Zhao J, Luo M, Chen J. Li G, et al. Curr Med Chem. 2021;28(3):607-627. doi: 10.2174/0929867327666200210144114. Curr Med Chem. 2021. PMID: 32039671 Review.
In this review, we describe the recent development of JNK inhibitors, including ATP competitive and ATP non-competitive (allosteric) inhibitors, bidentatebinding inhibitors and dual inhibitors, the challenges, and the future direction of JNK inhibitors as potential therape …
In this review, we describe the recent development of JNK inhibitors, including ATP competitive and ATP non-competitive (allosteric) inhibit …
Advances in Drug Therapy for Systemic Lupus Erythematosus.
Zhao X, Zhang J, Liang Y, Li J, Ding S, Wang Y, Chen Y, Liu J. Zhao X, et al. Curr Med Chem. 2021;28(6):1251-1268. doi: 10.2174/0929867327666200625150408. Curr Med Chem. 2021. PMID: 32586244 Review.
CONCLUSION: This article describes the pathogenesis of systemic lupus erythematosus, and summarizes the traditional and new therapeutic drugs, which is not only beneficial to the treatment of lupus erythematosus patients, but also plays a vital reference significance for the f
CONCLUSION: This article describes the pathogenesis of systemic lupus erythematosus, and summarizes the traditional and new therapeutic drug …
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases.
Cheng J, Feng X, Li Z, Zhou F, Yang JM, Zhao Y. Cheng J, et al. RSC Med Chem. 2021 Jan 22;12(4):552-565. doi: 10.1039/d0md00361a. eCollection 2021 Apr 28. RSC Med Chem. 2021. PMID: 34046627 Free PMC article. Review.
Information showcased in this review article might be helpful for the discovery and clinical development of the next generation of NIK inhibitors in the near future....
Information showcased in this review article might be helpful for the discovery and clinical development of the next generation of NIK inhib …
21 results